Boston Scientific Corporation (BSX)
Boston Scientific (BSX) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
The headline numbers for Boston Scientific (BSX) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
BSX Q4 Earnings & Revenues Top, Stock Falls on Weak Gross Margin
Boston Scientific's fourth-quarter 2024 performance reflects the strength of its core franchises.
Boston Scientific (BSX) Surpasses Q4 Earnings and Revenue Estimates
Boston Scientific (BSX) came out with quarterly earnings of $0.70 per share, beating the Zacks Consensus Estimate of $0.65 per share. This compares to earnings of $0.55 per share a year ago.
Boston Scientific sees higher-than-expected 2025 profit on strong demand
Medical device maker Boston Scientific forecast annual profit above Wall Street estimates on Wednesday, banking on steady demand for its heart devices.
What Analyst Projections for Key Metrics Reveal About Boston Scientific (BSX) Q4 Earnings
Evaluate the expected performance of Boston Scientific (BSX) for the quarter ended December 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Will Cheaper AI Models Like DeepSeek Become a Boon? 3 Stocks to Watch
As costs related to AI models may come down, as is evident from the cheaper DeepSeek model from China, MedTech companies developing AI-based solutions like SYK, BSX and TEM are likely to gain.
BSX Pre-Q4 Earnings: To Buy or Not to Buy Boston Scientific Stock Now?
Boston Scientific is expected to have registered strong growth in the Asia Pacific in the fourth quarter, led by strength in China and Japan.
Boston Scientific (BSX) Earnings Expected to Grow: Should You Buy?
Boston Scientific (BSX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Boston Scientific (BSX) Increases Despite Market Slip: Here's What You Need to Know
In the closing of the recent trading day, Boston Scientific (BSX) stood at $102.27, denoting a +0.32% change from the preceding trading day.
BSX Stock Rises on Positive Data Announcement at the AF Symposium
Boston Scientific announces favorable study data for its FARAPULSE PFA system and WATCHMAN FLX device at the AF Symposium 2025.
Boston Scientific (BSX) Increases Yet Falls Behind Market: What Investors Need to Know
Boston Scientific (BSX) closed the most recent trading day at $98.66, moving +0.5% from the previous trading session.
M&A Synergies Drive BSX: Is it Worth Buying the Stock Now?
Boston Scientific's recent acquisitions have added numerous products with immense potential.
